Sometimes complications (especially rare ones) are acknowledged for medications only after they have been in widespread use.
That's why it is a good idea to regularly check all of your medications for FDA black box warnings, voluntary manufacturer recalls, class action lawsuits, and also for changes in instructions or side effect listings.
We track some of the medications that are more commonly used by scleroderma patients and list new or recent warnings here. (Also see What is Scleroderma?, Medical Overview, and Medications for Scleroderma, Arthritis, Autoimmune and Rheumatic Diseases)
Warning Letters and Test Results for Cannabidiol–Related Products. Over the past several years, The US Food and Drug Administration (FDA) has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol (CBD). FDA, 11/02/2017. (Also see Endocannabinoid System)
Cautious ACE Inhibitor Use Needed in Scleroderma. This study suggests that ACE inhibitors should be used with great caution in patients with scleroderma, particularly early in disease when the risk of renal crisis is greatest. MedPageToday. (Also see Kidney Involvement and Hypertension)
FDA Warns of Fracture Risk From Acid Reflux Drugs. Popular PPI antacids -- Aciphex, Dexilant, Nexium, Prevacid, Prilosec, Protonix, Vimovo, and Zegerid -- raise the risk of bone fracture, especially when used for a year or more or at high doses, the FDA warns. Danial J. DeNoon. WebMD Health News.
Scleroderma Clinical Trials and Open Enrollments Includes proven treatments, unproven, open enrollments, pending results, and research registries. ISN.
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including Pam Hop, Margaret Roof, Winifred Schillberg, Arnold Slotkin, and Juliet Youkhana. Plus donations in honor of Kim Thwaits, and in loving memory of Marta Marx, Jim Miller, and Arlene Marie Petulla.
Click Here to Donate or Shop
or click on the floating green DONATE sclero.org button.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: